Matthew Franco M.D.

Matthew Franco, MD, currently serves as an Investments Senior Associate at Roivant Sciences since July 2019, where responsibilities include sourcing, assessing, and in-licensing new assets as well as ongoing company and portfolio strategy. Franco has also held roles as Investments Associate and Entrepreneur In Residence, notably as Medical Director of Alyvant. Since December 2019, Franco has worked as an Internal Medicine Physician at Settlement Health Inc, providing primary and urgent care. Training included residency at Columbia University Medical Center and New York-Presbyterian Hospital from June 2016 to June 2019. Educational credentials consist of a Doctor of Medicine (M.D.) degree from Florida International University's Herbert Wertheim College of Medicine and a Bachelor of Arts (B.A.) in Neuroscience from Colorado College.